Abstract:Sepsis-associated cerebral dysfunction is complex pathophysiology, generated from primary infections that are developed elsewhere in the body. The neonates, elderly population and chronically ill and long-term hospitalized patients are predominantly vulnerable to sepsis and related cerebral damage. Generally, electrophysiological recordings, severity and sedation scales, computerized imaging and spectroscopy techniques are used for its detection and diagnosis. About the underlying mechanisms, enhanced blood-brain barrier permeability and metalloprotease activity, tight junction protein loss and endothelial cell degeneration promote the influx of inflammatory and toxic mediators into the brain, triggering cerebrovascular damage. An altered neutrophil count and phenotype further dysregulate the normal neuroimmune responses and neuroendocrine stability via modulated activation of protein kinase C-delta, nuclear factor kappa-B and sphingolipid signaling. Glial activation, together with pro-inflammatory cytokines and chemokines and the Toll-like receptor, destabilize the immune system. Moreover, superoxides and hydroperoxides generate oxidative stress and perturb mitochondrial dynamics and ATP synthesis, propagating neuronal injury cycle. Activated mitochondrial apoptotic pathway, characterized by increased caspase-3 and caspase-9 cleavage and Bax/Bcl2 ratio in the hippocampal and cortical neurons, stimulate neurocognitive impairments. Additionally, altered LC3-II/I and P62/SQSTM1, p-mTOR, p-AMPK1 and p-ULK1 levels and dysregulated autophagosome-lysosome fusion decrease neuronal and glial energy homeostasis. The therapies and procedures for attenuating sepsis-induced brain damage include early resuscitation, cerebral blood flow autoregulation, implantable electric vagus nerve stimulation, antioxidants, statins, glucocorticoids, neuroimmune axis modulators and PKCδ inhibitors. The current review enumerates the pathophysiology of sepsis-induced brain damage, its diagnosis, the role of critical inducers and mediators and, ultimately, therapeutic measures attenuating cerebrovascular degeneration.

Pathogenesis of sepsis-associated encephalopathy: more than blood–brain barrier dysfunction

The Advance of Pathogenesis of Sepsis-Associated Encephalopathy

The role of the peripheral system dysfunction in the pathogenesis of sepsis-associated encephalopathy

Progress in Research of Pathogenesis of Septic Encephalopathy

Research progress in the pathogenesis of sepsis-associated encephalopathy

[Research progress on the changes of blood-brain barrier in sepsis-associated encephalopathy]

Neuroimmune Regulation in Sepsis-Associated Encephalopathy: The Interaction Between the Brain and Peripheral Immunity

Epidemiological Features and Risk Factors of Sepsis-Associated Encephalopathy in Intensive Care Unit Patients: 2008-2011.

Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment

Diagnosis and Pathophysiology of Septic-Associated Encephalopathy

Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies

Factors contributing to sepsis-associated encephalopathy: a comprehensive systematic review and meta-analysis

ROLE OF MICROGLIA IN SEPSIS-ASSOCIATED ENCEPHALOPATHY PATHOGENESIS: AN UPDATE

Basic research and clinical progress of sepsis-associated encephalopathy

Sepsis and Cerebral Dysfunction: BBB Damage, Neuroinflammation, Oxidative Stress, Apoptosis and Autophagy as Key Mediators and the Potential Therapeutic Approaches

Septic Encephalopathy: when Cytokines Interact with Acetylcholine in the Brain.

The biological alterations of synapse/synapse formation in sepsis-associated encephalopathy

Sepsis-associated encephalopathy: a vicious cycle of immunosuppression

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

The Key Drivers of Brain Injury by Systemic Inflammatory Responses after Sepsis: Microglia and Neuroinflammation

Application background and mechanism of short-chain fatty acids in sepsis-associated encephalopathy